GSK pharma acquires Novartis vaccine business

Q.  Drug firm GlaxoSmithKline Pharmaceuticals acquired which company’s vaccines business and divested its marketed oncology portfolio to them on 30th September 2015?
- Published on 01 Oct 15

a. Ranbaxy
b. Sun Pharmaceuticals
c. Novartis
d. None of the above

ANSWER: Novartis
 
GSK pharma has completed its transaction with Novartis Healthy Private Limited, acquiring the vaccine business of Novartis and divesting marketed oncology portfolio to Novartis India. This is the result of a transaction between Novartis and GSK on March 2015. Acquisition will give GSK opportunity to create a strong global vaccine business. As per the agreement, Novartis was to acquire GlaxoSmithKline plc’s (GSK) cancer drugs portfolio for USD 16 billion and sell its vaccines business in return for USD 7.1 billion, besides forming a JV for the consumer healthcare business in a 3-part transaction

Related Content

➨ Post your comment / Share knowledge


Enter the code shown above:

(Note: If you cannot read the numbers in the above image, reload the page to generate a new one.)
▲